Acute Olanzapine and Lipid Response
NCT04181385
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Olanzapine 10 milligram
DRUG:
Bromocriptine 5 milligram
DRUG:
Placebo oral tablet
Sponsor
University Health Network, Toronto